Neurodawn Pharmaceutical Co., Ltd.
Clinical trials sponsored by Neurodawn Pharmaceutical Co., Ltd., explained in plain language.
-
Scientists test new Drug's safety with common pills
Knowledge-focused CompletedThis study aimed to see if a new injectable drug, Y-3, changes how the body processes three common medications: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Researchers enrolled 24 healthy Chinese participants to take these medications w…
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
First human test for mystery drug Y-3
Knowledge-focused CompletedThis was the first study in people to check if a new drug called Y-3 is safe and to see how the body processes it. Twenty healthy adult volunteers in the US took either a single dose of the drug or a placebo (a dummy pill). Researchers closely monitored the participants for side …
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC